GBA Presents: House of Gummy-!

TrailerParkTed · Mar 13, 2024

stonedinvestor said:
NO SG NO HIMS.

--------------> SENTENEL 1 ready for blast off...( I hope)
More...

TrailerParkTed · Mar 13, 2024

vanzandt said:
I think some of these will do well this week Stoney. My market commentary at the bottom.

Earnings spotlight: Monday, March 4 - Sea Limited (SE), GitLab (GTLB), and Stitch Fix (SFIX).

Earnings spotlight: Tuesday, March 5 - Target (TGT), NIO (NIO), Ross Stores (ROST), Nordstrom (JWN), CrowdStrike (CRWD), and Box (BOX).

Earnings spotlight: Wednesday, March 6 - JD.com (JD), Brown-Forman (BF.A), Campbell Soup (CPB), Foot Locker (FL), Abercrombie & Fitch (ANF), and Victoria's Secret (VSCO).

Earnings spotlight: Thursday, March 7 - Kroger (KR), Bilibili (BILI), Costco (COST), Broadcom (AVGO), Gap (GPS), Marvell Technology (MRVL), and DocuSign (DOCU).

Earnings spotlight: Friday, March 8 - Genesco (GCO) and America's Car-Mart (CRMT). See the full earnings calendar.

Volatility watch: Options trading volume is still elevated on SoundHound AI (SOUN) and Barclays (BCS). The list of highly-shorted stocks heading into the new week includes Beyond Meat (BYND) and Cinemark Holdings (CNK). The most overbought stocks per their 14-day Relative Strength Index include Viking Therapeutics (VKTX), Vivani Medical, Inc. (VANI), and Caret Holdings, Inc. (ROOT). The most oversold stocks per their 14-day Relative Strength Index include AN2 Therapeutics (ANTX), Semilux International (SELX), and SSR Mining (SSRM).

IPO watch: No new IPO offerings are expected to launch in the week ahead. The post-IPO quiet periods expire on American Healthcare REIT (NYSE:AHR), Kyverna Therapeutics (KYTX), Telomir Pharmaceuticals (NASDAQ:TELO), Metagenomi (NASDAQ:MGX), and BBB Foods (TBBB) to free up analysts to post up ratings. A block of Solowin (SWIN) shares will see the IPO lockup period expire. Amer Sports (NYSE:AS) will release its first earnings report as a publicly traded company. The sporting goods stock traded about 25% above its IPO pricing level at the time of publication.

Investor events: A busy week of investor events includes American Airlines Group (AAL) Chief Executive Officer Robert Isom and senior leadership presenting at the company's Investor Day and Mattel (NASDAQ:MAT) providing a strategic business update. General Electric Company (GE) could also turn some heads when it holds a GE Aerospace Investor Day event with the aerospace leadership team. One of the more notable conferences of the year takes place next week with the Morgan Stanley Technology, Media and Telecom Conference scheduled for San Francisco. The event is expected to include updates on some of the latest trends in generative artificial intelligence and other themes shaping technology, media and telecom. Nvidia (NVDA), Netflix (NFLX), AMD (AMD), Disney (DIS), Palo Alto Networks (PANW), Coinbase Global (COIN), C3.ai (AI), Intel (INTC), Okta (OKTA), IMAX (IMAX), and Iron Mountain (IRM) are just some of the companies scheduled to participate. Meanwhile, BetMGM (OTCPK:GMVHF) (MGM) CEO Adam Greenblatt will be one of the notable speakers at the NEXT Summit New York, which is described as North America's premier iGaming and sports betting conference. Also keep an eye on Rivian Automotive (RIVN). The electric vehicle maker has an event scheduled in Laguna Beach, California to reveal its next-generation vehicle called the R2. The electric SUV model is expected to be smaller and cheaper than the R1S and R1T. The company has hinted that this model could be listed in the $40,000 to $60,000 range. Mass production of the R2 is not expected until 2026.

_________________________________________

STONEY GOES FOR 25 IN A ROW, JUST IGNORE THE LOSERS, THEY DON'T COUNT.

More...

Stoney your SOUN is $10 in AH.

vanzandt · Mar 14, 2024

stonedinvestor said:
I have mixed feelings here-- I mean you can go out to 2025 and still not making a profit so you can imagine a string of share sells... still a lot of folks are playing this for tomorrow: They have an approved pain med that has some expanded labeling.

HRTX- Heron Therapeutics, Inc.

$2.430.01 (+0.62%)3:08 PM 03/12/24
NASDAQ | $USD | Realtime
More...

How is this post "28 in a row?"

vanzandt · Mar 14, 2024

stonedinvestor said:
I have mixed feelings here-- I mean you can go out to 2025 and still not making a profit so you can imagine a string of share sells... still a lot of folks are playing this for tomorrow: They have an approved pain med that has some expanded labeling.

HRTX- Heron Therapeutics, Inc.

$2.430.01 (+0.62%)3:08 PM 03/12/24
NASDAQ | $USD | Realtime
More...

How is this post "28 in a row?"

stonedinvestor said:
28 In A Row~~~~~~~~~~~~~!
If you guys appreciate what I do for you all for free please let me know----!

GBA sell--> HRTX Heron Therapeutics, Inc.+ 35%

$3.190.83 (+35.17%)1:28 PM 03/13/24
NASDAQ | $USD | Realtime
More...

TrailerParkTed · Mar 14, 2024

Stoney every cowboy has been bucked off a horse, it sucks but you get back on!

stonedinvestor · Mar 14, 2024

stonedinvestor said:
SO FAR TA IS WINNING. 5 DAYS UP 5%

SE Sea Limited $44---$47 UNDER " NEGATIVE CATALYST WATCH " HURRUMPH

$47.05 +1.69(+3.73%)
More...

TA CRUSHES FUNDI!

GBA Call $44-------------------------> $60

WHY!!!! This is a huge F up by me.

stonedinvestor · Mar 14, 2024

vanzandt said:
How is this post "28 in a row?"
More...

Vz we have 27 winning Trades in a row here. OPENED AND CLOSED -I have not sold any losers of which I do have some.
But until I sell AND AS LONG AS I BOOK THESE GAINS. WE ARE ON A HAPPY TRAIL OF $$$$$$$'S

JOIN US! AS WE GO FOR THE RECORD OF 44!!!!!!!!!!

stonedinvestor · Mar 14, 2024

QUICK UPDATES))))

Goldman Sachs upgraded to Outperform from Neutral at Daiwa » 2 MOVE UPGRADE.

stonedinvestor said:
UPDATE- +$40

$195
More...

ANOTHER MASSIVE MISTAKE BY YOURS TRULY WAS NOT GETTING BACK IN WSM/

GBA IDEA $195-------------------$284.50

vanzandt · Mar 14, 2024

SENTINELONE--->$23.83

29 IN A ROW.

vanzandt · Mar 14, 2024

vanzandt said:
SENTINELONE--->$23.83

29 IN A ROW.
More...

My puts just made 100%.
I'm happy with 10 in a row.